← Back to search

PipeBio

PipeBio is a SaaS bioinformatics platform to develop antibody drugs.

Y CombinatorWinter 2021AcquiredHealthcareTherapeuticsAI-powered Drug DiscoveryMachine LearningSaaS

What they do

Problem

Antibody and peptide drug teams struggle to analyze, integrate, and manage massive sequencing and experimental datasets without specialized bioinformatics expertise, slowing discovery.

Solution

A cloud-based, highly visual SaaS bioinformatics platform for antibody/peptide screening that lets scientists upload, overlay, filter, and analyze sequencing and assay data to guide drug development.

Who it's for

Scientists and R&D teams at biotech and pharmaceutical companies developing antibody or peptide therapeutics.

Founders

Owen Bodley
Founder

CoFounder of PipeBio together with Jannick. Having a mechanical engineering background working in software engineering for the past ~7 years primarily in the field of Bioinformatics and specifically antibody drug discovery.

Jannick Bendtsen
Founder

More than 15 years of experience in commercial bioinformatics companies. Strong scientific background in molecular biology and bioinformatics and have been in several senior management positions. Enjoys running!

Company timeline

Similar startups